HQ: London, United Kingdom • Oncology Therapeutics • Infectious Disease Therapeutics • Vaccines • Prescription Drugs • 1001-5000 employees • Est. 2000 • Trust B • Hiring 559, 195 new
GSK is a British multinational pharmaceutical company that develops and manufactures prescription medicines and vaccines, with research focused on infectious diseases, HIV, respiratory and immunology, and oncology. It was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham and spun off its consumer healthcare business as Haleon in 2022. Listed in London and New York, it runs research, manufacturing and commercial operations worldwide. The company is headquartered in London, England, United Kingdom.
Anastasia Maksimova · HR
Careers mailbox is known
≈ $111k – $213k per year (Estimated) • Head+ • 12+ years exp • Philadelphia • San Francisco • Waltham • Remote (United States, United Kingdom) • Full-Time • GMP / cleanroom • Staff
$190k – $316k per year • Head+ • 10+ years exp • Providence • Waltham • Remote (United States) • Bachelor's Degree • Full-Time • Staff
$172k – $286k per year • Head+ • Hybrid (Waltham, Providence, United States, Wavre, Belgium, Durham, United Kingdom) • Bachelor's Degree • Full-Time • Architect
HQ: North Chicago, United States • Neurology & CNS Therapeutics • Oncology Therapeutics • Immunology & Inflammation Therapeutics • Prescription Drugs • 5000+ employees • Est. 2013 • NYSE: ABBV • Trust B • Hiring 978, 206 new
AbbVie is an American biopharmaceutical company created in 2013 when Abbott Laboratories separated its research-based drug business into a standalone listed company. It was built around the immunology drug Humira, once the highest selling medicine in the world, and has since replaced that revenue with the successor immunology drugs Skyrizi and Rinvoq, an oncology portfolio led by Imbruvica and Venclexta, neuroscience products including Botox Therapeutic and Vraylar, and the aesthetics business acquired with Allergan. Headquartered in North Chicago and listed on the New York Stock Exchange, it is one of the largest pharmaceutical companies by revenue.
Richard Gonzalez · Founding Chief Executive Officer · decision-maker
Laura Schumacher · Executive Officer · decision-maker
Carlos Alban · Executive Officer · decision-maker
William Chase · Executive Officer · decision-maker
No careers mailbox known
$161k – $305k per year • Head+ • 5+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Full-Time • Staff • English
$182k – $346k per year • Head+ • 17+ years exp • Hybrid (Waltham, United States) • PhD • Full-Time • Staff • English
$248k – $472k per year • Head+ • 15+ years exp • Hybrid (Waltham, United States) • Full-Time • Principal • English
HQ: Washington, United States • Laboratory Equipment • Bioprocessing • Diagnostic Tests & IVD • 1001-5000 employees • Est. 1969 • Trust A • Hiring 1160, 117 new
Danaher is an American science and technology conglomerate that owns businesses in life sciences, diagnostics and biotechnology. Its operating companies include Beckman Coulter, Cepheid, Radiometer and Leica Biosystems in clinical diagnostics, Cytiva and Pall in bioprocessing, and Leica Microsystems, SCIEX and Molecular Devices in research instruments, serving hospitals, laboratories and biopharmaceutical manufacturers. The group runs its companies through the Danaher Business System of continuous improvement. The company is headquartered in Washington, District of Columbia, United States.
No named decision-maker yet.
No careers mailbox known
≈ $57k – $102k per year (Estimated) • Junior • 2+ years exp • In office (Waltham, United States) • Bachelor's Degree • Full-Time • Junior
Microsoft Excel
Management
Oracle ERP
≈ $73k – $123k per year (Estimated) • Senior • 5+ years exp • In office (Cambridge, United Kingdom, Waltham, United States) • Bachelor's Degree • Full-Time • Senior
$73k – $100k per year • Senior • 4+ years exp • In office (Waltham, United States) • Full-Time • Senior
Dublin • Albany • Waltham • Wilmington • Athlone • Psychiatric Care • Biologics & Biosimilars • Health Care • 5000+ employees • Est. 2024 • NASDAQ: ALKS • Trust B • Hiring 32, 4 new
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience.
No named decision-maker yet.
No careers mailbox known
$116k – $137k per year • Staff+ • 10+ years exp • In office (Waltham, United States) • PhD • Staff
qPCR
ELISA
Western Blot
Immunohistochemistry
$145k – $157k per year • Hybrid (Waltham, United States)
$105k – $119k per year • Senior • 5+ years exp • In office (Waltham, United States) • Bachelor's Degree • GMP / cleanroom • Senior
Linux
AWS
Life Sciences
Veeva
HQ: Waltham, United States • CRO & CDMO Services • APIs & Drug Manufacturing • Clinical Trial Services (CRO) • Diagnostic Tests & IVD • Laboratory Equipment • 1001-5000 employees • Est. 2006 • NYSE: TMO • Trust B • Hiring 2649, 325 new
Founded in 2006 through a major merger, Thermo Fisher Scientific is a global leader in serving science, biotechnology, and healthcare. Headquartered in Waltham, Massachusetts, the multinational corporation provides a vast portfolio of analytical instruments, laboratory equipment, diagnostic tools, and pharmaceutical development services. By partnering with pharmaceutical companies, research institutions, and clinical laboratories worldwide, the organization enables clients to accelerate scientific discovery, optimize laboratory workflows, and improve patient diagnostics.
No named decision-maker yet.
No careers mailbox known
$175k – $255k per year • Equity • Head+ • 8+ years exp • In office (Carlsbad, Hillsboro, Waltham, Pittsburgh, Morrisville, United States) • Bachelor's Degree • Full-Time • Architect
$59k – $89k per year • Equity • Hybrid (Waltham, United States) • Bachelor's Degree • Full-Time
$180k – $200k per year • Equity • Waltham • Remote (United States) • Full-Time
HQ: Portage, United States • Neurotech & Neuromodulation • Hospital Equipment & Furniture • Surgical Instruments & Devices • Orthopedic & Spine Implants • 5000+ employees • Est. 1941 • NYSE: SYK • Trust B • Hiring 1372, 146 new
Stryker is an American medical technology company founded in 1941 by an orthopaedic surgeon who began manufacturing the mobility devices he had designed for his own patients. It sells hip and knee implants, trauma and extremity fixation, spinal implants, surgical power tools and navigation, neurovascular devices, hospital beds and stretchers, emergency response equipment, and the Mako robotic arm used for joint replacement. Listed on the New York Stock Exchange, it is one of the largest orthopaedic device makers in the world. The company is headquartered in Portage, Michigan, United States.
Preston Wells · Chief Financial Officer · decision-maker
Kevin Lobo · Chairman and Chief Executive Officer · decision-maker
Homer Stryker · Founder · founder
No careers mailbox known
$87k – $145k per year • In office (Waltham, United States) • Bachelor's Degree • Full-Time
GCP
Life Sciences
Good Clinical Practice
HQ: Paris, France • Vaccines • Rare Disease Therapeutics • Immunology & Inflammation Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1973 • NASDAQ: SNY • Trust A • Hiring 740, 122 new
Sanofi is a French pharmaceutical company formed in 1973 and assembled over five decades through a long series of mergers including Synthelabo, Aventis and Genzyme. It is now built around immunology and rare disease, with Dupixent for atopic dermatitis and asthma as by far its largest product, alongside a substantial vaccines division covering influenza, meningitis and the respiratory syncytial virus antibody Beyfortus. Headquartered in Paris, the group has sharpened its focus in recent years by separating its consumer healthcare business into the standalone company Opella and directing research spending toward biologics and immune science.
Frederic Oudéa · Président du conseil d’administration · decision-maker
Belen Garijo Lopez · Directeur Général, Administrateur · decision-maker
Audrey Duval · Director · decision-maker
Frederic Oudea · Chairman of the Board · decision-maker
No careers mailbox known
$70k – $120k per year • Hybrid (Waltham, United States) • Relocation • Master's Degree • Full-Time
MATLAB
Python
Life Sciences
Chromatography
Design of Experiments
$58k – $120k per year • In office (Waltham, United States) • Relocation • Bachelor's Degree • Full-Time
Python
AI/ML
Machine Learning
Scikit-learn
NumPy
TensorFlow
PyTorch
Chips/EDA
JMP
Life Sciences
Cell Culture
Design of Experiments
+1
$86k – $124k per year • Senior • 5+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Full-Time • Senior
HQ: Waltham, United States • Oncology Therapeutics • Prescription Drugs • Est. 2003 • Hiring 10, 2 new
Deciphera Pharmaceuticals is a biopharmaceutical company that discovers and develops kinase inhibitor drugs for cancer. Its marketed medicines include QINLOCK (ripretinib) for gastrointestinal stromal tumours and ROMVIMZA (vimseltinib) for tenosynovial giant cell tumour, with research operations in Lawrence, Kansas, and it was acquired by Ono Pharmaceutical in 2024. The company is headquartered in Waltham, Massachusetts, United States.
No named decision-maker yet.
Careers mailbox is known
$116k – $160k per year • Senior • 6+ years exp • Waltham • Remote (United States) • Bachelor's Degree • Full-Time • Middle • English
$141k – $194k per year • Senior • 8+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Full-Time • Senior • English
$292k – $403k per year • Head+ • Hybrid (Waltham, United States) • Full-Time • Senior • English
HQ: Fremont, Boston, United States • Health Care • 201-500 employees • NASDAQ: ARDX • Hiring 7, 2 new
Medicines that Matter. With a vision of creating a healthier tomorrow, we are steadfast in our commitment to deliver first-in-class medicines to patients with unmet medical needs.
Jeremy Caldwell · Executive Officer · decision-maker
Mark Kaufmann · Executive Officer · decision-maker
Jeff Jacobs · Executive Officer · decision-maker
Michael Raab · Executive Officer, Director · decision-maker
Careers mailbox is known
$211k – $257k per year • Equity • Head+ • 10+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Architect
HQ: Waltham, United States • CRO & CDMO Services • Cell & Gene Therapy • 201-500 employees • Est. 2017 • Startup • Hiring 16, 1 new
ElevateBio is a technology-driven company that helps partners realize the potential of their cell and gene therapies from design to commercialization. It combines technologies, end-to-end services and manufacturing expertise, and it hires validation engineers, quality assurance specialists and production planners. The company is headquartered in Waltham, Massachusetts, United States.
No named decision-maker yet.
Careers mailbox is known
$165k – $225k per year • Head+ • 5+ years exp • Hybrid (Waltham, United States) • Architect
PowerShell
Python
DevOps
TCP/IP
Windows
Linux
Cybersecurity
Zero Trust
NIST CSF
ISO 27001
$105k – $145k per year • Junior • 5+ years exp • In office (Waltham, United States) • Bachelor's Degree • GMP / cleanroom • Junior
$105k – $145k per year • Lead • 5+ years exp • In office (Waltham, United States) • Relocation • Bachelor's Degree • GMP / cleanroom • Staff
HQ: Waltham, United States • Biologics & Biosimilars • Drug Discovery • 51-200 employees • Est. 2020 • Startup • Hiring 9, 3 new
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in antibodies and TCRs.
Jay Rosanelli · Executive Officer · decision-maker
Logan Snyder · Director · decision-maker
Piotr Bobrowicz · Executive Officer, Director · decision-maker
Errik Anderson · Executive Officer, Director · decision-maker
Careers mailbox is known
$46k – $64k per year • In office (Waltham, United States) • Bachelor's Degree • Hazardous materials
≈ $115k – $203k per year (Estimated) • Senior • 6+ years exp • In office (Waltham, United States) • PhD • Senior
Mass Spectrometry
Chromatography
Flow Cytometry
≈ $69k – $147k per year (Estimated) • Junior • 5+ years exp • In office (Waltham, United States) • Bachelor's Degree • Junior
PCR
Antibody Engineering
Flow Cytometry
Cell Culture
Next-Generation Sequencing
HQ: Waltham, United States • Oncology Therapeutics • Biologics & Biosimilars • 1-10 employees • Est. 2016 • NASDAQ: CBIO • Trust A • Hiring 11, 1 new
Our bold vision is to build a world-leading oncology company. By focusing on the revolutionary shifts occurring in the field, we're aiming to transform cancer treatment and deliver the next standard of care for people living with cancer.
No named decision-maker yet.
Careers mailbox is known
≈ $97k – $284k per year (Estimated) • Head+ • 10+ years exp • In office (Waltham, United States) • Bachelor's Degree • Architect
≈ $103k – $304k per year (Estimated) • Head+ • 8+ years exp • In office (Waltham, United States) • Bachelor's Degree • GMP / cleanroom • Senior
Good Clinical Practice
LIMS
Medidata Rave
≈ $207k – $360k per year (Estimated) • Head+ • 8+ years exp • In office (Waltham, United States) • Bachelor's Degree • Full-Time • GMP / cleanroom • Architect
HQ: Cambridge, United Kingdom • Rare Disease Therapeutics • Cardiometabolic Therapeutics • Oncology Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 1999 • Trust A • Hiring 735, 200 new
AstraZeneca is a British-Swedish pharmaceutical company formed in 1999 by the merger of Astra of Sweden and Zeneca of the United Kingdom, and now one of the largest drug makers in the world by revenue. Its portfolio is concentrated in oncology with Tagrisso, Imfinzi and Enhertu, alongside cardiovascular, renal and metabolic products including Farxiga, respiratory and immunology medicines, and a rare disease business built on the acquisition of Alexion. Headquartered in Cambridge in England and listed in London, Stockholm and New York, it reports in United States dollars.
Aradhana Sarin · Chief Financial Officer · decision-maker
Pascal Soriot · Chief Executive Officer · decision-maker
Careers mailbox is known
$142k – $214k per year • Head+ • In office (South San Francisco, Waltham, United States) • PhD • Full-Time • Staff
Flow Cytometry
Next-Generation Sequencing
Immunohistochemistry
HQ: Waltham, United States • Rare Disease Therapeutics • Prescription Drugs • 201-500 employees • Est. 2017 • NASDAQ: DYN • Trust A • Hiring 21, 1 new
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).
Romesh Subramanian Ph.D. · Executive Officer · decision-maker
Oxana Beskrovnaya Ph.D. · Executive Officer · decision-maker
Jonathan McNeill M.D. · Executive Officer · decision-maker
Joshua Brumm · Executive Officer, Director · decision-maker
Careers mailbox is known
$160k – $200k per year • Head+ • 8+ years exp • In office (Waltham, United States) • Bachelor's Degree • Full-Time • Architect
HPLC
Chromatography
GMP
MedTech
CAPA
$265k – $300k per year • Head+ • 12+ years exp • In office (Waltham, United States) • PhD • Senior
$165k – $200k per year • Head+ • 8+ years exp • In office (Waltham, United States) • Staff
GCP
Life Sciences
Good Clinical Practice
MedTech
CAPA
Vilnius • Waltham • Biologics & Biosimilars • CRO & CDMO Services • 501-1000 employees • Hiring 4, 1 new
Northway Biotech is an end-to-end biologics CDMO with EU and US facilities for cell line, process and analytical development, plus cGMP manufacturing.
No named decision-maker yet.
No careers mailbox known
≈ $120k – $229k per year (Estimated) • Lead • 8+ years exp • In office (Waltham, United States) • Bachelor's Degree • Full-Time • GMP / cleanroom • Staff
≈ $68k – $124k per year (Estimated) • Middle • 3+ years exp • In office (Waltham, United States) • Bachelor's Degree • Full-Time • GMP / cleanroom • Middle
SQL
DevOps
VPN
VMWare
Windows
Linux
Management
SharePoint
HQ: Waltham, United States • Oncology Therapeutics • Trust B • Hiring 13, 1 new
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
No named decision-maker yet.
Careers mailbox is known
≈ $117k – $205k per year (Estimated) • Equity • Senior • 6+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Senior
GCP
Management
SharePoint
Life Sciences
Good Clinical Practice
Veeva
≈ $110k – $194k per year (Estimated) • Equity • Senior • 3+ years exp • Hybrid (Waltham, United States) • Bachelor's Degree • Senior
SharePoint
Life Sciences
Good Clinical Practice
≈ $177k – $308k per year (Estimated) • Equity • Head+ • 5+ years exp • Hybrid (Waltham, United States) • PhD • GMP / cleanroom • Architect
GCP
Life Sciences
PCR
Flow Cytometry
Next-Generation Sequencing
Immunohistochemistry
GLP
HQ: Waltham, United States • Immunology & Inflammation Therapeutics • Biologics & Biosimilars • Est. 2020 • NASDAQ: ZBIO • Trust B • Hiring 14, 2 new
Zenas BioPharma is a clinical-stage global biopharmaceutical company developing and commercializing therapies for patients with autoimmune diseases. It identifies, acquires and develops product candidates globally and hires medical, legal, biomarker and statistical programming leaders. The company is headquartered in Waltham, Massachusetts, United States.
Hua Mu · Executive Officer, Director · decision-maker
Tanya Fischer · Executive Officer · decision-maker
Jennifer Fox · Executive Officer · decision-maker
Leon Moulder Jr. · Executive Officer, Director · decision-maker
Careers mailbox is known
≈ $81k – $239k per year (Estimated) • Head+ • 8+ years exp • In office (Waltham, Boston, United States) • Bachelor's Degree • Architect
≈ $177k – $308k per year (Estimated) • Head+ • 3+ years exp • In office (Waltham, Boston, United States) • PhD • Architect
≈ $85k – $249k per year (Estimated) • Head+ • 12+ years exp • In office (Waltham, Boston, United States) • PhD • Architect
HQ: Stockholm, Sweden • Biologics & Biosimilars • Rare Disease Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 2010 • Hiring 63, 17 new
Sobi, legally known as Swedish Orphan Biovitrum AB, is an international biopharmaceutical company headquartered in Stockholm, Sweden, and was formed in 2010 through a merger. The company specializes in the development and distribution of therapies for rare diseases, with a primary focus on haematology, immunology, and specialty care treatments. It operates globally with a presence in more than 30 countries, providing access to medicines for patients in over 70 countries through its own operations and strategic partnerships.
No named decision-maker yet.
Careers mailbox is known
$215k – $230k per year • Senior • 5+ years exp • Waltham • Remote (United States) • PhD • Full-Time • Senior • English
HQ: Conshohocken, United States • Cardiometabolic Therapeutics • Prescription Drugs • 1001-5000 employees • Est. 2008 • NASDAQ: MDGL • Trust A • Hiring 30, 1 new
Madrigal Pharmaceuticals is a biopharmaceutical company dedicated to developing novel therapies for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH. The company achieved a landmark milestone by developing Rezdiffra (resmetirom), which became the first FDA-approved treatment specifically targeting MASH with liver fibrosis. Headquartered in Pennsylvania, Madrigal focuses on transforming the care landscape for patients facing serious liver and metabolic diseases.
No named decision-maker yet.
Careers mailbox is known
$266k – $308k per year • Head+ • 15+ years exp • In office (Conshohocken, Waltham, United States) • Bachelor's Degree • Full-Time • Senior
Microsoft Fabric
Snowflake
Databricks
AI/ML
Tokenization
DevOps
Incident Management
Azure
Cybersecurity
HIPAA
Analytics
Master Data Management
Alation
Tableau
ETL/ELT
Power BI
Life Sciences
Veeva
+5
$259k – $293k per year • Head+ • 15+ years exp • Hybrid (Waltham, Conshohocken, United States) • Bachelor's Degree • Full-Time • Senior
$286k – $334k per year • Head+ • 10+ years exp • In office (Conshohocken, Waltham, United States) • Bachelor's Degree • Full-Time • Staff
HQ: Melbourne, Australia • Vaccines • Biologics & Biosimilars • 5000+ employees • Est. 1916 • Trust B • Hiring 135, 14 new
CSL Limited is a global biotechnology and biopharmaceutical enterprise specializing in lifesaving medicines and public health solutions. The company focuses on researching, developing, and manufacturing plasma-derived therapies, influenza vaccines, recombinant proteins, and treatments for iron deficiency and nephrology conditions through its operating divisions - CSL Behring, CSL Seqirus, and CSL Vifor. Headquartered in Melbourne, Australia, it maintains extensive research, manufacturing, and donor collection networks to deliver specialized biological therapies and vaccines to patients in over 100 countries worldwide.
No named decision-maker yet.
No careers mailbox known
≈ $172k – $323k per year (Estimated) • Head+ • 12+ years exp • In office (King of Prussia, Waltham, United States) • Bachelor's Degree • Full-Time • Architect
Python
Databases
Snowflake
Databricks
AI/ML
Scikit-learn
Human-in-the-Loop
Multi-Agent Systems
TensorFlow
PyTorch
RAG
Machine Learning
AI Agents
DevOps
AWS
+4
$129k – $153k per year • Lead • 5+ years exp • Hybrid (Waltham, King of Prussia, United States) • Relocation • Bachelor's Degree • Full-Time • Staff
$186k – $220k per year • Head+ • 10+ years exp • Hybrid (King of Prussia, Waltham, United States) • Relocation • PhD • Full-Time • Staff
Power BI
Management
Smartsheet
